Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Inflammatory breast cancer as a mimic

Essential points for quick revision.

Saved on this device
!
Cancer concern does not replace acute sepsis care

Hypotension, confusion or severe spreading infection still requires immediate resuscitation and source-control assessment even when inflammatory cancer is possible.

Action: Treat physiological instability now while arranging urgent breast diagnostic input; infection and malignancy can coexist and must be investigated in parallel.

Synopsis

Recognise inflammatory breast cancer within apparent mastitis, trigger urgent imaging and representative biopsy when inflammation is atypical or non-resolving, and avoid diagnostic delay from repeated empirical antibiotics.

  • Inflammatory breast cancer is a clinical pattern of rapid erythema, oedema and enlargement caused by dermal lymphatic tumour involvement, often without a discrete palpable mass.
  • Mastitis is more likely during lactation with pain, fever and milk-stasis triggers, but age or breastfeeding status alone cannot exclude cancer.
  • Features of concern include peau d’orange, diffuse skin thickening, rapid progression, nipple change, abnormal nodes, absent pus and failure to respond to appropriate antibiotics and drainage.

Key red flags

Diffuse peau d’orange, rapid breast enlargement, nipple retraction or abnormal nodes without a drainable collection requires urgent suspected-cancer assessment.

Investigation priorities

01
Bilateral diagnostic mammographyFirst step

Identify mass, distortion, calcification, skin thickening and disease distribution.

Management branches

Non-resolving mastitis pathwayEscalate after failed appropriate treatment

A non-lactating 58-year-old has diffuse erythema and swelling without an abscess and no improvement after a suitable antibiotic course.

  1. Reassess the entire breast and nodes, documenting area of skin involvement, peau d’orange, nipple change, temperature and systemic state.
  2. Use the suspected-cancer route under NG12 rather than prescribing a second empirical course without a new infective finding.
Open full textbook Answer 2 questions
Sources and review status6 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom